Scientists scan brains to see how plant compound fights opioid cravings
NCT ID NCT07226570
Summary
This study aims to understand how ibogaine, a plant-derived compound, might change brain function in people with opioid use disorder. Researchers will use brain scans and surveys to measure changes in brain activity, chemistry, and cravings in 20 participants who are already scheduled to receive ibogaine treatment at a licensed clinic outside the U.S. The goal is to learn how ibogaine works in the brain, which could inform future treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER (OUD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Susan Samueli Integrative Health Institute, University of California, Irvine
RECRUITINGIrvine, California, 92617, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.